| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-28 12:56:43 UTC |
|---|
| Updated at | 2022-04-28 12:56:43 UTC |
|---|
| NP-MRD ID | NP0068048 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Isobonafousine |
|---|
| Description | Methyl (1R,15R,17S,18S)-5-[(5R,7R)-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]Hexadeca-9(16),10,12,14-tetraen-7-yl]-17-ethyl-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]Nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. Isobonafousine is found in Bonafousia tetrastachya and Tabernaemontana siphilitica Leeuwenberg. Based on a literature review very few articles have been published on methyl (1R,15R,17S,18S)-5-[(5R,7R)-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]Hexadeca-9(16),10,12,14-tetraen-7-yl]-17-ethyl-6-hydroxy-3,13-diazapentacyclo[13.3.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]Nonadeca-2(10),4(9),5,7-tetraene-1-carboxylate. |
|---|
| Structure | CC[C@H]1C[C@H]2CN3CCC4=C(NC5=C([C@H]6CC7=C8[C@@H](CCCN8C8=CC=CC=C78)N6)C(O)=CC=C45)[C@@](C2)([C@H]13)C(=O)OC InChI=1S/C35H40N4O3/c1-3-20-15-19-17-35(34(41)42-2)32-23(12-14-38(18-19)33(20)35)22-10-11-28(40)29(30(22)37-32)26-16-24-21-7-4-5-9-27(21)39-13-6-8-25(36-26)31(24)39/h4-5,7,9-11,19-20,25-26,33,36-37,40H,3,6,8,12-18H2,1-2H3/t19-,20+,25-,26-,33+,35+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Methyl (1R,15R,17S,18S)-5-[(5R,7R)-1,6-diazatetracyclo[7.6.1.0,.0,]hexadeca-9(16),10,12,14-tetraen-7-yl]-17-ethyl-6-hydroxy-3,13-diazapentacyclo[13.3.1.0,.0,.0,]nonadeca-2(10),4(9),5,7-tetraene-1-carboxylic acid | Generator |
|
|---|
| Chemical Formula | C35H40N4O3 |
|---|
| Average Mass | 564.7300 Da |
|---|
| Monoisotopic Mass | 564.31004 Da |
|---|
| IUPAC Name | Not Available |
|---|
| Traditional Name | Not Available |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC[C@H]1C[C@H]2CN3CCC4=C(NC5=C([C@H]6CC7=C8[C@@H](CCCN8C8=CC=CC=C78)N6)C(O)=CC=C45)[C@@](C2)([C@H]13)C(=O)OC |
|---|
| InChI Identifier | InChI=1S/C35H40N4O3/c1-3-20-15-19-17-35(34(41)42-2)32-23(12-14-38(18-19)33(20)35)22-10-11-28(40)29(30(22)37-32)26-16-24-21-7-4-5-9-27(21)39-13-6-8-25(36-26)31(24)39/h4-5,7,9-11,19-20,25-26,33,36-37,40H,3,6,8,12-18H2,1-2H3/t19-,20+,25-,26-,33+,35+/m1/s1 |
|---|
| InChI Key | YZKISHBNBLHLTP-KFPKMPRHSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | | Species Name | Source | Reference |
|---|
| Bonafousia tetrastachya | Plant | | | Tabernaemontana siphilitica Leeuwenberg | Plant | |
|
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as ibogan-type alkaloids. These are indole alkaloids with a structure based on the ibogamine skeleton or a derivative thereof. Ibogamine is a pentacyclic heterocyclic compound consisting of an indole fused to an azepane-containing tricyclic moiety ring. Iboga alkaloids arise from the cyclization of a secodine-type precursor through the formation of a 16,21 bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Ibogan-type alkaloids |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Ibogan-type alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Ibogan skeleton
- Catharanthine skeleton
- Indolo[3,2-1de][1,5]naphthyridine
- Pyridoindole
- Beta-carboline
- Diazanaphthalene
- Hydroxyindole
- 3-alkylindole
- Pyrroloazepine
- Naphthyridine
- Piperidinecarboxylic acid
- Indole or derivatives
- Indole
- 1-hydroxy-2-unsubstituted benzenoid
- Aralkylamine
- Azepine
- Benzenoid
- Piperidine
- Heteroaromatic compound
- Methyl ester
- Pyrrole
- Tertiary aliphatic amine
- Tertiary amine
- Carboxylic acid ester
- Amino acid or derivatives
- Azacycle
- Organoheterocyclic compound
- Secondary amine
- Monocarboxylic acid or derivatives
- Secondary aliphatic amine
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Amine
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|